North America Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Cardiac Disease Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Cardiac Disease Market, North America, Revenue ($m), 2018-2033
3.2 Cardiac Disease Market, North America, Revenue ($m), 2018-2033
3.3 Cardiac Disease Market, North America, Volume (Units), 2018-2033
3.4 Cardiac Disease Market, North America, Volume (Units), 2018-2033
3.5 Cardiac Disease Market, North America, Company Share by Revenue ($m), 2024

4.1 Cardiac Disease Market, Canada, Revenue ($m), 2018-2033
4.1.1 Cardiac Marker Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Cardiac Disease Market, Canada, Volume (Units), 2018-2033
4.2.1 Cardiac Marker Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Cardiac Disease Market, Canada, Average Price ($), 2018-2033
4.4 Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2024

5.1 Cardiac Disease Market, United States, Revenue ($m), 2018-2033
5.1.1 Cardiac Marker Tests Market, United States, Revenue ($m), by Segment, 2018-2033
5.2 Cardiac Disease Market, United States, Volume (Units), 2018-2033
5.2.1 Cardiac Marker Tests Market, United States, Volume (Units), by Segment, 2018-2033
5.3 Cardiac Disease Market, United States, Average Price ($), 2018-2033
5.4 Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024

6.1 Cardiac Disease Market, Mexico, Revenue ($m), 2018-2033
6.1.1 Cardiac Marker Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
6.2 Cardiac Disease Market, Mexico, Volume (Units), 2018-2033
6.2.1 Cardiac Marker Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
6.3 Cardiac Disease Market, Mexico, Average Price ($), 2018-2033
6.4 Cardiac Disease Market, Mexico, Company Share by Revenue ($m), 2024

7.1 F. Hoffmann-La Roche Ltd
7.1.1 Company Overview
7.2 Abbott Laboratories
7.2.1 Company Overview
7.3 Beckman Coulter Inc
7.3.1 Company Overview
7.4 Quidel Corp
7.4.1 Company Overview
7.5 Siemens Healthineers AG
7.5.1 Company Overview
7.6 bioMerieux SA
7.6.1 Company Overview

9.1 Corporate Communications
9.1.1 Mar 03, 2025: Pulnovo secures $100m to advance clinical trials and business expansion
9.2 Government and Public Interest
9.2.1 Feb 11, 2025: New Implant May Help Patients Regenerate Their Own Heart Valves
9.3 Other Significant Developments
9.3.1 Oct 09, 2024: Heart Health for All: How We Can Improve Access to Cardiac Care around the Globe
9.3.2 Oct 08, 2024: Amwell Expands Clinical Programs Portfolio to Include Hello Heart Cardiovascular Health Risk Management Solution
9.4 Product News
9.4.1 Jun 09, 2025: Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of Its FIH Study
9.4.2 Apr 28, 2025: Simple Blood Test Could Better Predict Heart Disease Risk
9.4.3 Feb 28, 2025: Allegheny General Hospital First in Western PA to Participate in Clinical Trial Using Artificial Intelligence to Detect Deep Vein Thrombosis in Cardiac Patients
9.4.4 Jan 28, 2025: New Data Finds 31% of Working Americans and Their Families Have a Cardiac Disorder
9.4.5 Jan 09, 2025: Peerbridge Health Unveils Cor-Insight Trial To Validate Revolutionary Ai-Enabled Cardiac and Cardiopulmonary Diagnostics & Monitoring
9.4.6 Dec 16, 2024: Streamlining Analysis of Ion Channel in Vitro Assays Data to Support Clinical Cardiac Safety Decision-Making
9.4.7 Sep 30, 2024: New Wearable Laser Device Monitors Brain Blood Flow to Gauge Stroke Risk
9.4.8 Aug 20, 2024: Brigham Researchers Use AI Tools to Uncover Connections Between Radiotherapy for Lung Cancer and Heart Complications
9.4.9 Aug 19, 2024: American Chemical Society : Improving Access to Heart-Failure Screening with Saliva
9.4.10 Jun 27, 2024: SoftWave TRT Affiliate Study Featured in Prominent Medical Journal
9.5 Strategy And Business Planning
9.5.1 Dec 18, 2024: Medera’s Novoheart Enters Into Transformative Partnership With Curi Bio
9.5.2 Jul 29, 2024: TELUS and University of Ottawa Heart Institute partner to boost emergency cardiac care efficiency with smartphone app
9.5.3 Jun 27, 2024: Elucid Moves into New Headquarters in Preparation for Commercial Launch

10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Benchmarking
10.2 the analyst Consulting
10.3 Contact the Publisher
10.4 Disclaimer

Table 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Cardiac Disease Market, North America, Volume (Units), 2018-2033
Table 4: Cardiac Disease Market, North America, Volume (Units), 2018-2033
Table 5: Cardiac Disease Market, North America, Company Share by Revenue ($m), 2024
Table 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: Cardiac Disease Market, Canada, Volume (Units), 2018-2033
Table 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2018-2033
Table 10: Cardiac Disease Market, Canada, Average Price ($), 2018-2033
Table 11: Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2024
Table 12: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 13: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 14: Cardiac Disease Market, United States, Volume (Units), 2018-2033
Table 15: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033
Table 16: Cardiac Disease Market, United States, Average Price ($), 2018-2033
Table 17: Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024
Table 18: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 19: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 20: Cardiac Disease Market, Mexico, Volume (Units), 2018-2033
Table 21: Cardiac Marker Tests Market, Mexico, Volume (Units), 2018-2033
Table 22: Cardiac Disease Market, Mexico, Average Price ($), 2018-2033
Table 23: Cardiac Disease Market, Mexico, Company Share by Revenue ($m), 2024
Table 27: Cardiac Disease Market Pipeline Products
Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figure 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cardiac Disease Market, North America, Volume (Units), 2018-2033
Figure 4: Cardiac Disease Market, North America, Volume (Units), 2018-2033
Figure 5: Cardiac Disease Market, North America, Company Share (%), 2024
Figure 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: Cardiac Disease Market, Canada, Volume (Units), 2018-2033
Figure 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2018-2033
Figure 10: Cardiac Disease Market, Canada, Company Share (%), 2024
Figure 11: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 12: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 13: Cardiac Disease Market, United States, Volume (Units), 2018-2033
Figure 14: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033
Figure 15: Cardiac Disease Market, United States, Company Share (%), 2024
Figure 16: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 17: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 18: Cardiac Disease Market, Mexico, Volume (Units), 2018-2033
Figure 19: Cardiac Marker Tests Market, Mexico, Volume (Units), 2018-2033
Figure 20: Cardiac Disease Market, Mexico, Company Share (%), 2024